AstraZeneca PLC ADR (AZN) is a multinational biopharmaceutical company headquartered in Cambridge, England. This pharmaceutical giant is engaged in the research, development, and manufacturing of prescription medicines, primarily for the treatment of diseases in three areas: Oncology, Cardiovascular, Renal &
Metabolism (CVRM), and Respiratory & Immunology.
AstraZeneca PLC was established in 1999 following the merger of Astra AB from Sweden and Zeneca Group plc from the UK. It is a publicly listed company, and its American Depositary Receipts (ADRs) are traded on the New York Stock Exchange under the ticker symbol AZN. An ADR represents ownership in shares of a foreign company and serves as an alternative for investors interested in buying shares directly from the company's home market.
AstraZeneca has distinguished itself with pioneering innovations and partnerships that improve the health of millions around the world. The company has a rich portfolio of products that addresses various diseases and conditions, including asthma, heart disease, diabetes, and various forms of cancer. AstraZeneca's vigorous research and development (R&D) strategy constitute a significant aspect of its business philosophy, contributing extensively to its product innovation.
AstraZeneca's consistent focus on innovation has given it a substantial growth platform, with a robust pipeline of potential new medicines. The company's commitment to developing these products through close collaborations with scientists, academic institutions, and biotech companies is equally remarkable.
In the year 2020, AstraZeneca gained worldwide attention for its role in developing one of the leading COVID-19 vaccines in collaboration with the University of Oxford. It was among the first pharmaceutical companies to have a vaccine approved for emergency use by the World Health Organization. Today, AstraZeneca is a leading global provider of COVID-19 vaccines and has committed to providing the vaccine at no profit during the pandemic.
AstraZeneca PLC's pursuit of science and innovation, its commitment to improving patient health, and its global footprint make it not only an important player in the pharmaceutical industry but also a key contributor to global health solutions.